1. Home
  2. GKOS vs ADC Comparison

GKOS vs ADC Comparison

Compare GKOS & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ADC
  • Stock Information
  • Founded
  • GKOS 1998
  • ADC 1971
  • Country
  • GKOS United States
  • ADC United States
  • Employees
  • GKOS N/A
  • ADC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ADC Real Estate Investment Trusts
  • Sector
  • GKOS Health Care
  • ADC Real Estate
  • Exchange
  • GKOS Nasdaq
  • ADC Nasdaq
  • Market Cap
  • GKOS 6.7B
  • ADC 7.5B
  • IPO Year
  • GKOS 2015
  • ADC 1994
  • Fundamental
  • Price
  • GKOS $129.10
  • ADC $75.89
  • Analyst Decision
  • GKOS Strong Buy
  • ADC Buy
  • Analyst Count
  • GKOS 12
  • ADC 13
  • Target Price
  • GKOS $131.33
  • ADC $73.35
  • AVG Volume (30 Days)
  • GKOS 459.7K
  • ADC 782.4K
  • Earning Date
  • GKOS 11-04-2024
  • ADC 10-22-2024
  • Dividend Yield
  • GKOS N/A
  • ADC 4.00%
  • EPS Growth
  • GKOS N/A
  • ADC 1.77
  • EPS
  • GKOS N/A
  • ADC 1.79
  • Revenue
  • GKOS $341,725,000.00
  • ADC $583,006,000.00
  • Revenue This Year
  • GKOS $21.14
  • ADC N/A
  • Revenue Next Year
  • GKOS $24.12
  • ADC $7.87
  • P/E Ratio
  • GKOS N/A
  • ADC $42.36
  • Revenue Growth
  • GKOS 15.14
  • ADC 20.68
  • 52 Week Low
  • GKOS $59.22
  • ADC $52.69
  • 52 Week High
  • GKOS $136.61
  • ADC $77.30
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 52.41
  • ADC 59.47
  • Support Level
  • GKOS $127.01
  • ADC $72.71
  • Resistance Level
  • GKOS $130.36
  • ADC $76.88
  • Average True Range (ATR)
  • GKOS 3.13
  • ADC 1.07
  • MACD
  • GKOS -0.02
  • ADC 0.10
  • Stochastic Oscillator
  • GKOS 62.26
  • ADC 76.26

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-leading tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

Share on Social Networks: